Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage.

The EMBO journal | Jul 2, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11432841

The evolutionarily conserved protein kinases Mec1 and Rad53 are required for checkpoint response and growth. Here we show that their role in growth is to remove the ribonucleotide reductase inhibitor Sml1 to ensure DNA replication. Sml1 protein levels fluctuate during the cell cycle, being lowest during S phase. The disappearance of Sml1 protein in S phase is due to post-transcriptional regulation and is associated with protein phosphorylation. Both phosphorylation and diminution of Sml1 require MEC1 and RAD53. More over, failure to remove Sml1 in mec1 and rad53 mutants results in incomplete DNA replication, defective mitochondrial DNA propagation, decreased dNTP levels and cell death. Interestingly, similar regulation of Sml1 also occurs after DNA damage. In this case, the regulation requires MEC1 and RAD53, as well as other checkpoint genes. Therefore, Sml1 is a new target of the DNA damage checkpoint and its removal is a conserved function of Mec1 and Rad53 during growth and after damage.

Pubmed ID: 11432841 RIS Download

Mesh terms: Cell Cycle Proteins | Checkpoint Kinase 2 | DNA Damage | DNA Repair | DNA Replication | DNA, Fungal | Enzyme Inhibitors | Fungal Proteins | Gamma Rays | Genotype | Hydroxyurea | Intracellular Signaling Peptides and Proteins | Protein Kinases | Protein-Serine-Threonine Kinases | Ribonucleotide Reductases | Saccharomyces cerevisiae | Saccharomyces cerevisiae Proteins | Ultraviolet Rays

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, Id: GM50237
  • Agency: NIGMS NIH HHS, Id: R01 GM080670

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.